Characterization of intestinal and pancreatic dysfunction in VPAC1-Null mutant mouse

Pancreas

Volumn 40, Issue 6, 2011, Pages 861-871

  Fabricius, Dorit ^a   Karacay, Bahri ^b   Shutt, Damon ^b   Leverich, Whitney ^b   Schafer, Blanca ^b   Takle, Erika ^b   Thedens, Daniel ^b   Khanna, Geetika ^b,c   Raikwar, Sudhanshu ^b   Yang, Baoli ^b   Desmond, Mary E ^d   O'Dorisio, Mary Sue ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF IOWA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VILLANOVA UNIVERSITY   (United States)

Author keywords

intestine; pancreas; VPAC1 null mutant mouse

Indexed keywords

BETA GALACTOSIDASE; GLUCOSE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FAILURE TO THRIVE; FEMALE; GENE DELETION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HETEROZYGOTE; HISTOPATHOLOGY; HYPOGLYCEMIA; INTESTINE EPITHELIUM CELL; INTESTINE FUNCTION; INTESTINE OBSTRUCTION; MALE; MOUSE; NONHUMAN; NULL ALLELE; PANCREAS FUNCTION; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET DELTA CELL; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE; WILD TYPE;

ANIMALS; BASE SEQUENCE; BLOOD GLUCOSE; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE TARGETING; GLUCOSE TOLERANCE TEST; HETEROZYGOTE; HOMOZYGOTE; INTESTINES; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PANCREAS; PREGNANCY; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I;

EID: 80051549752     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318214c783     Document Type: Article

References (78)

1. Laburthe M, Couvineau A, Tan V. Class II G protein-coupled receptors for VIP and PACAP: Structure, models of activation and pharmacology. Peptides. 2007;28:1631-1639. (Pubitemid 47371033)
2. Couvineau A, Ceraudo E, Tan YV, et al. VPAC1 receptor binding site: Contribution of photoaffinity labeling approach. Neuropeptides. 2010;44:127Y132.
3. Wu ZC, O'Dorisio TM, Cataland S, et al. Effects of pancreatic polypeptide and vasoactive intestinal polypeptide on rat ileal and colonic water and electrolyte transport in vivo. Dig Dis Sci. 1979;24:625-630. (Pubitemid 9226980)
4. Krejs GJ, Fordtran JS, Fahrenkrug J, et al. Effect of VIP infusion in water and ion transport in the human jejunum. Gastroenterology. 1980;78:722-727. (Pubitemid 10103167)
5. Lundberg JM, Fahrenkrug J, Hokfelt T, et al. Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man. Peptides. 1984;5:593-606. (Pubitemid 14089210)
6. Power RF, Bishop AE, Wharton J, et al. Anatomical distribution of vasoactive intestinal peptide binding sites in peripheral tissues investigated by in vitro autoradiography. Ann N Y Acad Sci. 1988;527:314-325.
7. Gressens P, Hill JM, Gozes I, et al. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature. 1993;362:155-158. (Pubitemid 23085254)
8. Steingart RA, Solomon B, Brenneman DE, et al. VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress. J Mol Neurosci. 2000;15:137Y145.
9. Delgado M, Gonzalez-Rey E, Ganea D. VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells. FASEB J. 2004;18:1453-1455. (Pubitemid 39561612)
10. O'Dorisio MS. Biochemical characteristics of receptors for vasoactive intestinal polypeptide in nervous, endocrine, and immune systems. Fed Proc. 1987;46:192-195. (Pubitemid 17056342)
11. Lara-Marquez M, O'Dorisio M, O'Dorisio T, et al. Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells. J Immunol. 2001;166:2522-2530. (Pubitemid 32173489)
12. Fabricius D, O'Dorisio MS, Blackwell S, et al. Human plasmacytoid dendritic cell function: Inhibition of IFN-{alpha} secretion and modulation of immune phenotype by vasoactive intestinal peptide. J Immunol. 2006;177:5920-5927. (Pubitemid 44628805)
13. Harmar AJ, Sheward WJ, Morrison CF, et al. Distribution of the VPAC2 receptor in peripheral tissues of the mouse. Endocrinology. 2004;145:1203-1210. (Pubitemid 38281001)
14. Zaben M, Sheward WJ, Shtaya A, et al. The neurotransmitter VIP expands the pool of symmetrically dividing postnatal dentate gyrus precursors via VPAC2 receptors or directs them toward a neuronal fate via VPAC1 receptors. Stem Cells. 2009;27:2539-2551.
15. Cunha-Reis D, Ribeiro JA, Sebastiao AM. VPAC2 receptor activation mediates VIP enhancement of population spikes in the CA1 area of the hippocampus. Ann N Y Acad Sci. 2006;1070:210-214. (Pubitemid 44126644)
16. Basille M, Falluel-Morel A, Vaudry D, et al. Ontogeny of PACAP receptors in the human cerebellum: Perspectives of therapeutic applications. Regul Pept. 2006;137:27Y33.
17. Jolivel V, Basille M, Aubert N, et al. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates. Neuroscience. 2009;160:434-451.
18. Otto C, Hein L, Brede M, et al. Pulmonary hypertension and right heart failure in pituitary adenylate cyclase-activating polypeptide type I receptor-deficient mice. Circulation. 2004;110: 3245-3251. (Pubitemid 39525073)
19. Cummings KJ, Pendlebury JD, Sherwood NM, et al. Sudden neonatal death in PACAP-deficient mice is associated with reduced respiratory chemoresponse and susceptibility to apnoea. J Physiol. 2004;555:15-26. (Pubitemid 38313059)
20. Martinez C, Abad C, Delgado M, et al. Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor. Proc Natl Acad Sci U S A. 2002;99:1053-1058. (Pubitemid 34106634)
21. Otto C, Martin M, Wolfer DP, et al. Altered emotional behavior in PACAP-type-I-receptor-deficient mice. Brain Res Mol Brain Res. 2001;92:78-84. (Pubitemid 32718707)
22. Jamen F, Puech R, Bockaert J, et al. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC. Endocrinology. 2002;143:1253-1259. (Pubitemid 34274354)
23. Jamen F, Alonso G, Shibuya I, et al. Impaired somatodendritic responses to pituitary adenylate cyclase-activating polypeptide (PACAP) of supraoptic neurones in PACAP type I - receptor deficient mice. J Neuroendocrinol. 2003;15:871-881. (Pubitemid 37038613)
24. Voice JK, Grinninger C, Kong Y, et al. Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice. J Immunol. 2003;170:308-314. (Pubitemid 36026154)
25. Goetzl EJ, Voice JK, Shen S, et al. Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide. Proc Natl Acad Sci U S A. 2001;98:13854-13859. (Pubitemid 33115988)
26. Harmar AJ, Marston HM, Shen S, et al. The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei. Cell. 2002;109:497Y508.
27. Hughes AT, Fahey B, Cutler DJ, et al. Aberrant gating of photic input to the suprachiasmatic circadian pacemaker of mice lacking the VPAC2 receptor. J Neurosci. 2004;24:3522-3526. (Pubitemid 38481108)
28. Summers MA, O'Dorisio MS, Cox MO, et al. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects. J Pharmacol Exp Ther. 2003;306:638-645. (Pubitemid 36886163)
29. Robberecht P, Chatelain P, De Neef P, et al. Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes. Biochim Biophys Acta. 1981;678:76-82. (Pubitemid 12218949)
30. Nakata M, Kohno D, Shintani N, et al. PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus. Neurosci Lett. 2004;370:252-256. (Pubitemid 39370889)
31. Hashimoto H, Shintani N, Tanaka K, et al. Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci U S A. 2001;98: 13355-13360. (Pubitemid 33051367)
32. Gray SL, Yamaguchi N, Vencova P, et al. Temperature-sensitive phenotype in mice lacking pituitary adenylate cyclase-activating polypeptide. Endocrinology. 2002;143:3946-3954. (Pubitemid 35244374)
33. Mukai K, Takeuchi T, Toyoshima M, et al. PACAP- and PHI-mediated sustained relaxation in circular muscle of gastric fundus: Findings obtained in PACAP knockout mice. Regul Pept. 2006;133:54-61. (Pubitemid 41820336)
34. Karacay B, O'Dorisio MS, Summers M, et al. VIP receptor 1 (VPAC1) promoter targets the expression of a reporter gene to cerebellum and adrenal medulla in transgenic mice. Regul Pept. 2003; 116:1-12. (Pubitemid 37352909)
35. Couvineau A, Rouyer-Fessard C, Darmoul D, et al. Human intestinal VIP receptor: Cloning and functional expression of two cDNA encoding proteins with different N-terminal domains. Biochem Biophys Res Commun. 1994;200:769-776. (Pubitemid 24146029)
36. Bronson SK, Smithies O. Altering mice by homologous recombination using embryonic stem cells. J Biol Chem. 1994;269:27155-27158. (Pubitemid 24346525)
37. Raikwar SP, Zavazava N. Real-time non-invasive imaging of ES cell-derived insulin producing cells. Methods Mol Biol. 2009;590:317Y334.
38. Todaro GJ, Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol. 1963;17:299-313.
39. Wenger GD, O'Dorisio MS, Campolito LB. Assays for vasoactive intestinal peptide receptors. Methods in Neurosciences. 1991;5: 362-385.
40. McPherson GA. Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. J Pharmacol Methods. 1985;14:213-228. (Pubitemid 15241175)
41. Sterio DC. The unbiased estimation of number and sizes of arbitrary particles using the dissector. J Microsc. 1984;134:127Y136.
42. Gundersen HJ, Jensen EB. Stereological estimation of the volume-weighted mean volume of arbitrary particles observed on random sections. J Microsc. 1985;138:127Y142.
43. Ahren B. The insulin response to gastric glucose is reduced in PAC1 and GRP receptor gene deleted mice. Nutr Metab Cardiovasc Dis. 2006;16(suppl 1):S17YS21.
44. Taborsky GJ Jr, Ahren B, Mundinger TO, et al. Autonomic mechanism and defects in the glucagon response to insulin-induced hypoglycaemia. Diabetes Nutr Metab. 2002;15:318-322.
45. Tan YV, Couvineau A, Murail S, et al. Peptide agonist docking in the N-terminal ectodomain of a class II G protein-coupled receptor, the VPAC1 receptor. Photoaffinity, NMR, and molecular modeling. J Biol Chem. 2006;281:12792-12798. (Pubitemid 43855371)
46. Guo MM, Huang MH,Wang CH, et al. [Changes of vasoactive intestinal polypeptide and vasoactive intestinal polypeptide receptor 1 in small intestine and liver during macaque development]. Sheng Li Xue Bao. 2007;59:163-168.
47. Saha JK, Xia J, Grondin JM, et al. Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: Mechanisms and implications for preclinical models. Exp Biol Med (Maywood). 2005;230:777Y784.
48. Said SI, Mutt V. Polypeptide with broad biological activity: Isolation from small intestine. Science. 1970;169:1217Y1218.
49. Fontaine-Perus JC, Chanconie M, Le Douarin NM. Differentiation of peptidergic neurones in quail-chick chimaeric embryos. Cell Differ. 1982;11:183-193. (Pubitemid 12090332)
50. Cochard P, Le Douarin NM. Development of the intrinsic innervation of the gut. Scand J Gastroenterol Suppl. 1982;71:1-14. (Pubitemid 12192409)
51. Tsutsumi M, Claus TH, Liang Y, et al. A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: A potential therapy for type 2 diabetes. Diabetes. 2002;51:1453-1460. (Pubitemid 34826611)
52. Borboni P, Porzio O, Pierucci D, et al. Molecular and functional characterization of pituitary adenylate cyclase-activating polypeptide (PACAP-38)/vasoactive intestinal polypeptide receptors in pancreatic beta-cells and effects of PACAP-38 on components of the insulin secretory system. Endocrinology. 1999;140:5530-5537. (Pubitemid 30645340)
53. Filipsson K, Sundler F, Hannibal J, et al. PACAP and PACAP receptors in insulin producing tissues: Localization and effects. Regul Pept. 1998;74:167Y175.
54. Rachdi L, Marie JC, Scharfmann R. Role for VPAC2 receptorYmediated signals in pancreas development. Diabetes. 2003;52:85-92. (Pubitemid 36042111)
55. Aton SJ, Colwell CS, Harmar AJ, et al. Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nat Neurosci. 2005;8:476-483. (Pubitemid 41007565)
56. Shintani N, Hashimoto H, Baba A. Altered higher brain function in PACAP-knockout mice. Nippon Yakurigaku Zasshi. 2004;123:274-280. (Pubitemid 38478385)
57. Durie PR, Kent G, Phillips MJ, et al. Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model. Am J Pathol. 2004;164:1481-1493. (Pubitemid 38387813)
58. Derand R, Montoni A, Bulteau-Pignoux L, et al. Activation of VPAC1 receptors by VIP and PACAP-27 in human bronchial epithelial cells induces CFTR-dependent chloride secretion. Br J Pharmacol. 2004;141:698-708. (Pubitemid 38453262)
59. Savagner P, Valles AM, Jouanneau J, et al. Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells. Mol Biol Cell. 1994;5:851-862. (Pubitemid 24283766)
60. Savagner P. Leaving the neighborhood: Molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays. 2001;23:912-923. (Pubitemid 32972691)
61. Cabrera O, Berman DM, Kenyon NS, et al. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A. 2006;103:2334-2339. (Pubitemid 43271670)
62. Alexander FE, Patheal SL, Biondi A, et al. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res. 2001;61:2542-2546. (Pubitemid 32685836)
63. Tharakan T, Kirchgessner AL, Baxi LV, et al. Appearance of neuropeptides and NADPH-diaphorase during development of the enteropancreatic innervation. Brain Res Dev Brain Res. 1995;84:26-38.
64. Kirchgessner AL, Liu MT. Immunohistochemical localization of nicotinic acetylcholine receptors in the guinea pig bowel and pancreas. J Comp Neurol. 1998;390:497Y514.
65. Kirchgessner AL, Liu MT, Gershon MD. In situ identification and visualization of neurons that mediate enteric and enteropancreatic reflexes. J Comp Neurol. 1996;371:270-286. (Pubitemid 26260016)
66. Kirchgessner AL, Liu MT. Pituitary adenylate cyclase activating peptide (PACAP) in the enteropancreatic innervation. Anat Rec. 2001;262:91-100. (Pubitemid 32061917)
67. Gaidar YA, Lepekhin EA, Sheichetova GA, et al. Distribution of N-cadherin and NCAM in neurons and endocrine cells of the human embryonic and fetal gastroenteropancreatic system. Acta Histochem. 1998;100:83-97. (Pubitemid 28101529)
68. Boonen K, Baggerman G, D'Hertog W, et al. Neuropeptides of the islets of Langerhans: A peptidomics study. Gen Comp Endocrinol. 2007;152:231-241. (Pubitemid 46950889)
69. Winzell MS, Ahren B. Role of VIP and PACAP in islet function. Peptides. 2007;28:1805-1813. (Pubitemid 47361423)
70. Gershengorn MC, Hardikar AA, Wei C, et al. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science. 2004;306:2261-2264. (Pubitemid 40024464)
71. Hayek A. In search of endocrine progenitor/stem cells in the human pancreas. Pediatr Diabetes. 2004;5(suppl 2):70-74. (Pubitemid 40081360)
72. Means AL, Meszoely IM, Suzuki K, et al. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development. 2005;132:3767Y3776.
73. Kim SK, Hebrok M. Intercellular signals regulating pancreas development and function. Genes Dev. 2001;15:111-127. (Pubitemid 32107658)
74. Brissova M, Fowler M, Wiebe P, et al. Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. Diabetes. 2004;53:1318-1325. (Pubitemid 38569019)
75. Tiso N, Filippi A, Pauls S, et al. BMP signalling regulates anteroposterior endoderm patterning in zebrafish. Mech Dev. 2002;118:29-37. (Pubitemid 35292119)
76. Kumar M, Jordan N, Melton D, et al. Signals from lateral plate mesoderm instruct endoderm toward a pancreatic fate. Dev Biol. 2003;259:109-122. (Pubitemid 36703147)
77. Balemans W, Van HW. Extracellular regulation of BMP signaling in vertebrates: A cocktail of modulators. Dev Biol. 2002;250: 231-250. (Pubitemid 35216412)
78. Satin LS, Kinard TA. Neurotransmitters and their receptors in the islets of Langerhans of the pancreas: What messages do acetylcholine, glutamate, and GABA transmit? Endocrine. 1998;8:213-223. (Pubitemid 28350810)